4 Lui Paster
Tel Aviv-Jaffa 6803605
Israel
972 5 2775 5072
https://www.raphaelpharmaceutical.com
Secteur(s): Healthcare
Secteur d’activité: Drug Manufacturers - Specialty & Generic
Employés à temps plein:
Nom | Titre | Payer | Exercé | Année de naissance |
---|---|---|---|---|
Mr. Shlomo Pilo | CEO & Chairman | 244k | S.O. | 1955 |
Mr. Guy Ofir | CFO & Director | 144k | S.O. | 1973 |
Dr. Igal Louria Hayon | CTO & Director | S.O. | S.O. | 1973 |
Raphael Pharmaceutical Inc., a pharmaceutical drug research and development company, focuses on the discovery and clinical development of life-improving drug therapies based on cannabinoids. The company develops product candidate for the treatment of rheumatoid arthritis and hyper inflammatory syndrome inflammation related to COVID-19. It also intends to develop product candidate to treat oncology indications. The company is headquartered in Tel Aviv-Jaffa, Israel.
L’ISS Governance QualityScore de Raphael Pharmaceutical Inc. en date du S.O. est S.O.. Les scores principaux sont Audit : S.O.; Société : S.O.; Droits des actionnaires : S.O.; Compensation : S.O..